Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedFeb 07, 2026
DataAggregated Company Financials
Companies10
- 7D-0.5%
- 3M19.3%
- 1Y19.8%
- YTD0.2%
Over the last 7 days, the Pharma industry has remained flat, although notably Merck KGaA declined by 3.3%. The past year has been better, since the industry has gained 20% in that time. Earnings are forecast to grow by 21% annually.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 07 Feb 2026 | €100.6b | €68.3b | €2.9b | 17.4x | 35.1x | 1.5x |
| Mon, 05 Jan 2026 | €92.9b | €68.3b | €2.9b | 17.9x | 32.4x | 1.4x |
| Wed, 03 Dec 2025 | €87.4b | €68.5b | €2.9b | 17.2x | 30.3x | 1.3x |
| Fri, 31 Oct 2025 | €78.4b | €68.8b | -€439,051,605.37 | 19.6x | -178.6x | 1.1x |
| Sun, 28 Sep 2025 | €76.1b | €68.8b | -€439,004,563.70 | 18.7x | -173.3x | 1.1x |
| Tue, 26 Aug 2025 | €78.5b | €68.9b | -€409,718,943.84 | 17.6x | -191.7x | 1.1x |
| Thu, 24 Jul 2025 | €79.2b | €69.4b | -€283,071,598.00 | 17.6x | -280x | 1.1x |
| Sat, 21 Jun 2025 | €76.6b | €69.4b | -€293,702,195.00 | 17.3x | -260.8x | 1.1x |
| Mon, 19 May 2025 | €74.7b | €69.4b | -€206,564,479.00 | 17.7x | -361.7x | 1.1x |
| Wed, 16 Apr 2025 | €74.8b | €69.3b | €467.0m | 18.2x | 160.1x | 1.1x |
| Fri, 14 Mar 2025 | €83.6b | €69.2b | €436.0m | 21x | 191.7x | 1.2x |
| Sun, 09 Feb 2025 | €84.2b | €69.2b | €2.0b | 22.6x | 41.6x | 1.2x |
| Tue, 07 Jan 2025 | €84.4b | €69.2b | €2.0b | 23.1x | 42x | 1.2x |
| Thu, 05 Dec 2024 | €82.8b | €69.2b | €2.0b | 21.7x | 40.8x | 1.2x |
| Sat, 02 Nov 2024 | €93.9b | €69.4b | €1.6b | 20.1x | 60.2x | 1.4x |
| Mon, 30 Sep 2024 | €102.1b | €69.4b | €1.5b | 24.6x | 69.3x | 1.5x |
| Wed, 28 Aug 2024 | €104.1b | €69.3b | €1.4b | 30.4x | 71.9x | 1.5x |
| Fri, 26 Jul 2024 | €97.0b | €69.2b | -€303,627,757.00 | 29.2x | -319.5x | 1.4x |
| Sun, 23 Jun 2024 | €100.6b | €69.2b | -€327,989,929.00 | 30.3x | -306.7x | 1.5x |
| Tue, 21 May 2024 | €103.2b | €69.2b | -€318,587,180.00 | 21.6x | -323.9x | 1.5x |
| Thu, 18 Apr 2024 | €92.1b | €70.0b | -€34,208,180.00 | 20x | -2692.2x | 1.3x |
| Sat, 16 Mar 2024 | €96.5b | €70.0b | €6.5m | 19.8x | 14855.6x | 1.4x |
| Mon, 12 Feb 2024 | €96.1b | €70.6b | -€650,504,143.00 | 19.8x | -147.8x | 1.4x |
| Wed, 10 Jan 2024 | €99.9b | €70.6b | -€650,504,143.00 | 19.8x | -153.6x | 1.4x |
| Fri, 08 Dec 2023 | €96.7b | €70.6b | -€650,606,256.00 | 18.3x | -148.7x | 1.4x |
| Sun, 05 Nov 2023 | €107.5b | €72.1b | €4.7b | 17.6x | 23x | 1.5x |
| Tue, 03 Oct 2023 | €116.1b | €72.1b | €4.7b | 20.3x | 24.8x | 1.6x |
| Thu, 31 Aug 2023 | €124.7b | €72.1b | €4.6b | 22.2x | 26.9x | 1.7x |
| Sat, 29 Jul 2023 | €124.2b | €74.1b | €6.5b | 17.3x | 19.3x | 1.7x |
| Mon, 26 Jun 2023 | €119.2b | €74.2b | €6.4b | 18.5x | 18.5x | 1.6x |
| Wed, 24 May 2023 | €128.5b | €74.0b | €6.4b | 22.3x | 20.2x | 1.7x |
| Fri, 21 Apr 2023 | €132.6b | €74.2b | €7.6b | 19.7x | 17.4x | 1.8x |
| Sun, 19 Mar 2023 | €129.0b | €74.2b | €7.7b | 17.3x | 16.8x | 1.7x |
| Tue, 14 Feb 2023 | €142.3b | €72.8b | €8.4b | 15.3x | 17x | 2x |
Price to Earnings Ratio
17x
Current Industry PE
- Investors are pessimistic on the German Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 35.1x which is lower than its 3-year average PE of 132x.
- The industry is trading close to its 3-year average PS ratio of 1.4x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 30% per year over the last three years,
- Revenues have also declined 2.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | 0.82% | |
| Healthcare | 0.43% | |
| Pharma | -0.48% | |
| Pharma | -0.48% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BAYN Bayer | €45.80 | 2.8% +€1.2b | 118.7% | PS1x | |
| DMP Dermapharm Holding | €36.35 | 4.3% +€80.8m | -6.8% | PE16.9x | |
| HIGH Cantourage Group | €4.00 | 14.9% +€6.5m | -15.6% | PS25.5x |
